Handok targets 353 billion won in sales this year

Published: 2011-02-09 06:56:00

Updated: 2011-02-09 06:56:00

Handok Pharmaceutical aims to achieve 351.3 billion won in this year’s sales with the intention of emerging as one of the best-performing companies here, a company executive said.

“We will achieve the sales target with our quality products,’’ said Kim Young-jin, Handok’s Chairman.

The annou...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK